Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (UNCOVER‐J)
暂无分享，去创建一个
H. Nakagawa | K. Sayama | Koichiro Nakamura | Hidetoshi Takahashi | A. Kawada | H. Ihn | M. Takahara | M. Kawashima | Y. Umezawa | G. Cameron | K. Kabashima | T. Hashimoto | M. Seishima | R. Okuyama | T. Shiohara | T. Ishii | K. Tanese | K. Takehara | Y. Asano | A. Ozawa | O. Osuntokun | K. Iwatsuki | K. Yamanaka | T. Akasaka | A. Igarashi | Y. Fujita | H. Saeki | T. Etoh | Y. Okubo | K. Nakajo | Y. Morisaki | T. Aoki | M. Higashiyama | M. Tani | Hideaki Watanabe | T. Ishii